SHIELD THERA
SHARE PRICE
10.25
CHANGE
0.00 ( 0%)
TICKER
STX.L
Share Chart
Latest Articles for STX.L
Shield Therapeutics upbeat as Accrufer trial initiated in Japan
(Alliance News) - Shield Therapeutics PLC on Friday reported the commencement of a phase two Accrufer trial in Japan for the treatment of pulmonary arterial hypertension. ...
IN BRIEF: Shield receives approval from South Korea for Accrufer
(Alliance News) - Shield Therapeutics PLC - Newcastle, England-based commercial-stage pharmaceutical company - Announces that the Korean Ministry of Food and Drug Safety has granted regulatory approval for Accrufer in...
TRADING UPDATES: Shoe Zone wary ahead of budget; Nexus sales jump 16%
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:...
Shield Therapeutics reports positive results in paediatric trial
(Alliance News) - Shield Therapeutics PLC on Wednesday noted positive efficacy and tolerance results from in its phase three ferric maltol Fortis trial....